Content about Integrase inhibitor

July 19, 2011

Ranbaxy will produce and market three HIV/AIDS drugs that currently are in late-stage clinical development by Gilead under a new licensing agreement between the drug makers.

© 2014 Drug Store News. All Rights Reserved.